Novogen Limited KZIA
9.51
(0.27)
(2.76%)
as of 25 Sep
- Market cap
- $111.8M
- P/E
- 0.0×
Follow KZIA
| Dec '25 | Jun '25 | Dec '24 | Jun '24 | Older periods | |
|---|---|---|---|---|---|
| ROE | 0.00% | 0.00% | 0.00% | 0.00% |
+8 more TTM periods Free account |
| ROA | 0.00% | 0.00% | 0.00% | 0.00% | |
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% | |
| Return on Tangible Assets | 0.00% | 0.00% | 0.00% | 0.00% | |
| Average Days of Receivables | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | (26.63) | (24.50) | (26.10) | (26.41) | |
| Capital Expenditures | — | 0.00 | — | 0.00 | |
| Other line items | |||||
| Cash ROIC | (34.97%) | 1,062.27% | 6,636.16% | 521.24% | |
| Accounts Receivable Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Accounts Payable Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Average Days of Payables | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Based Compensation of Revenue | 0.00% | — | 0.00% | — | |
| Operating CF/Net income | 0.00 | 0.00 | 0.00 | 0.00 | |
| Depreciation/Fixed assets | — | 0.00 | 0.00 | 0.00 | |
| Capex/Depreciation | — | 0.00 | 0.00 | 0.00 | |
| Operating CF per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capex per Share | — | 0.00 | — | 0.00 | |
| Capex to Sales | — | 0.00 | — | 0.00 |
Columns are period end dates